Vimarsana
Biggest News Aggregation in the World

Page 17 - Et Now News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Et Now. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Et Now Today - Breaking & Trending Today

portfolio allocation: Ajay Srivastava on 3 big changes in the portfolio in 3 months - Vimarsana News

portfolio allocation: Ajay Srivastava on 3 big changes in the portfolio in 3 months

Ajay Srivastava of Dimensions Corporate says "we are in that zone where people are comfortable where they are and therefore willing to carry the investment and also make more investment. So, yes, there are fundamental factors, but to me the most important is human psychology. We are feeling good today and when we feel good, we want to do things and become more expensive."

india-mauritius tax treaty: Can taxation treaty amendment lead to sizable reduction in flows from Mauritius? Deloitte's Rajesh Gandhi explains - Vimarsana News

india-mauritius tax treaty: Can taxation treaty amendment lead to sizable reduction in flows from Mauritius? Deloitte's Rajesh Gandhi explains

Rajesh Gandhi from Deloitte India explains the implications of including Mauritius in the PPT requirement, affecting investments pre-2017. Uncertainty looms over treaty benefits and potential challenges for entities choosing Mauritius for non-tax reasons.

stocks to buy now: Constructive on markets, 2 stocks to buy now: Sudeep Shah - Vimarsana News

stocks to buy now: Constructive on markets, 2 stocks to buy now: Sudeep Shah

Sudeep Shah, from SBI Securities, predicts market consolidation and bullish movement towards 22,950-23,000. He further Recommends Aditya Birla Capital and MCX stocks and anticipates positive trends in the pharma sector, specifically mentioning Concord Bio.

TCS share price | TCS Q4 earnings: Mayuresh Joshi on why TCS stock deserves to be rerated - Vimarsana News

TCS share price | TCS Q4 earnings: Mayuresh Joshi on why TCS stock deserves to be rerated

Market expert Joshi praises TCS's outstanding financial performance, expecting a stock re-rating. Anticipates positive sector impact and growth in BFSI, energy, manufacturing, life sciences, and healthcare industries based on TCS's stellar results.

cdmo: Foram Parekh on what to bet on in pharma pack - Vimarsana News

cdmo: Foram Parekh on what to bet on in pharma pack

Foram Parekh shares insights on CDMO companies' positive outlook post-Covid correction, potential impact of Biosecure Law, concerns about Laurus's earnings improvement, Sun Pharma's specialty sales focus, and recommendations for pharma sector growth with Lupin and Dr Reddy's.